Description
Miconazole is an imidazole antifungal compound that inhibits ergosterol synthesis and fungal cell wall formation. Miconazole is clinically used to treat fungal infections and is especially active against Candida. Miconazole also exhibits anti-angiogenic activities, decreasing expression of HIF-1α and VEGF in breast cancer and glioma cells. Additionally, this compound may inhibit glucocorticoid receptors.
References
Park JY, Jung HJ, Seo I, et al. Translational suppression of HIF-1α by miconazole through the mTOR signaling pathway. Cell Oncol (Dordr). 2014 Jul 29. [Epub ahead of print]. PMID: 25070654.
Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology. 2010 Feb;98(1):15-25. PMID: 20155503.
Duret C, Daujat-Chavanieu M, Pascussi JM, et al. Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor. Mol Pharmacol. 2006 Jul;70(1):329-39. PMID: 16608920.
ABOUT LKT LABS
LKT Laboratories is a biochemical supply company focused on the synthesis, purification, and isolation of small molecules for research applications. Its range of products exhibit known biological activities that have found uses in a wide array of research fields, especially cancer and neuroscience. These products include protein kinase inhibitors, ion channel modulators, and activators. LKT serves the global research community by supplying the highest purity products for use in cell culture models, animal studies, or as reference materials or analytical standards.